Report cover image

Chronic Idiopathic Constipation Market -Global Trends and Forecasts(2025 to 2034)

Publisher Factview Research
Published Nov 02, 2025
Length 202 Pages
SKU # FAVR20572998

Description

Chronic Idiopathic Constipation Market Size And Forecast

According to Factview Research, Global Chronic Idiopathic Constipation Market is expected to grow at a CAGR of 7.5% from 2025 to 2034.

Global Chronic Idiopathic Constipation Market Outlook

The factors such as the increasing prevalence of irritable bowel syndrome with constipation, rising use of opioid drugs, and growing geriatric population across the globe are expected to boom the growth of the Global chronic idiopathic constipation market. Moreover, the growing number of patients having GI diseases and disorders due to change in dietary patterns is the major factor boosting the market growth. On the other hand, low awareness about guidelines for diagnosis and treatment methods of idiopathic constipation is likely to limit the market growth.

Global Chronic Idiopathic Constipation Market Competitive Landscape

The Global Chronic Idiopathic Constipation Market study report will provide a valuable insight with an emphasis on Global market including some of the major players such as GlaxoSmithKline Plc., Astellas Pharma, Inc., Synergy Pharmaceuticals, Inc., Bayer AG, Allergan Plc., Ironwood Pharmaceuticals, Inc., Sanofi S.A., and Pfizer, Inc.

Table of Contents

202 Pages
1 Introduction Of Global Chronic Idiopathic Constipation Market
1.1 Overview Of The Market
1.2 Scope Of Report
1.3 Assumptions
2 Executive Summary
3 Research Methodology Of Factview Research
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List Of Data Sources
4 Global Chronic Idiopathic Constipation Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Chronic Idiopathic Constipation Market, By Diagnosis
5.1 Overview
5.2 Blood Tests
5.3 Sigmoidoscopy
5.4 Colonoscopy
5.5 Balloon Expulsion Test
5.6 Others
6 Global Chronic Idiopathic Constipation Market, By Treatment
6.1 Overview
6.2 Drug
6.3 Surgery
7 Global Chronic Idiopathic Constipation Market, By End-user
7.1 Overview
7.2 Hospitals And Diagnostic Centers
7.3 Gastroenterology Clinics
7.4 Others
8 Global Chronic Idiopathic Constipation Market, By Geography
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest Of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest Of Asia Pacific
8.5 Rest Of The World
8.5.1 Latin America
8.5.2 Middle East
9 Global Chronic Idiopathic Constipation Market Competitive Landscape
9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies
10 Company Profiles
10.1 Glaxosmithkline Plc.
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Astellas Pharma, Inc.
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Synergy Pharmaceuticals, Inc.
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Bayer Ag
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Allergan Plc.
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Ironwood Pharmaceuticals, Inc.
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Sanofi S.A.
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Pfizer, Inc
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
11 Appendix
11.1 Related Research

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us